ADVANCED TECHNOLOGIES FOR NOVEL THERAPEUTICS, LLC

ADVANCED TECHNOLOGIES FOR NOVEL THERAPEUTICS, LLC is a women-owned small business focused on advancing novel therapeutic development through cutting-edge biotechnological innovation. While specific contract details are not available, the company’s name and certifications suggest deep specialization in the research, design, and preclinical development of next-generation therapeutics, potentially including biologics, gene therapies, or targeted drug delivery systems. Their technical expertise likely encompasses molecular biology, pharmacokinetic modeling, formulation science, and regulatory strategy for FDA-aligned pathways. As a woman-owned business certified under federal programs, the company brings a commitment to diversity and agile R&D execution in highly regulated environments. No agency relationships can be inferred from available data, as no award history or top contracting agencies are listed. Consequently, there is no demonstrable pattern of engagement with federal departments such as NIH, DoD, or VA. No primary NAICS codes are available to define the company’s market verticals, but based on its name and industry context, it is positioned within the biopharmaceutical innovation space, likely supporting early-stage therapeutic discovery and translational research. The company’s focus appears to be on high-complexity, high-value biological interventions rather than broad-spectrum pharmaceutical manufacturing. The business operates as a small entity based in Millburn, New Jersey, with formal certifications as a Women-Owned Small Business and Woman-Owned Business under federal small business programs. This positions it to compete for set-aside contracts in the life sciences sector and aligns with federal initiatives promoting diversity in scientific innovation. Its geographic presence in New Jersey—a hub for biopharma R&D—supports collaboration with academic institutions, clinical research organizations, and biotech incubators.